Patrick Hwu
12Patents
3h-index
18Co-inventors
57Inventor score
Filing activity: Oct 24, 1995 → Apr 11, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8211422B2 | Chimeric receptor genes and cells transformed therewith | Chemistry; Metallurgy | 172 | Expired |
| US7723111B2 | Activated dual specificity lymphocytes and their methods of use | Chemistry; Metallurgy | 28 | Expired |
| US6734014B1 | Methods and compositions for transforming dendritic cells and activating T cells | Chemistry; Metallurgy | 23 | Expired |
| US7419957B2 | Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic methods | Physics | 3 | Expired |
| US9512401B2 | B and T lymphocyte attenuator marker for use in adoptive T-cell therapy | Human Necessities | 2 | Active |
| US7378277B2 | Methods and compositions for transforming dendritic cells and activating T cells | Chemistry; Metallurgy | 2 | Expired |
| US7749967B2 | Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods | Physics | 1 | Active |
| US12171803B2 | Methods of CD40 and toll like receptor immune activation | Chemistry; Metallurgy | 0 | Active |
| US11594135B2 | Methods of CD40 activation and immune checkpoint blockade | Electricity | 0 | Active |
| US10894044B2 | Combination of topoisomerase-I inhibitors with immunotherapy in the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
| US11673966B2 | Monoclonal and humanized antibodies to a cancer glycopeptide | Chemistry; Metallurgy | 0 | Active |
| US8252545B2 | Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.